Center for the Study of Systems Biology, School of Biology, Georgia Institute of Technology, Atlanta, Georgia.
Med Res Rev. 2019 Mar;39(2):684-705. doi: 10.1002/med.21538. Epub 2018 Sep 7.
Escherichia coli Dihydrofolate reductase is an important enzyme that is essential for the survival of the Gram-negative microorganism. Inhibitors designed against this enzyme have demonstrated application as antibiotics. However, either because of poor bioavailability of the small-molecules resulting from their inability to cross the double membrane in Gram-negative bacteria or because the microorganism develops resistance to the antibiotics by mutating the DHFR target, discovery of new antibiotics against the enzyme is mandatory to overcome drug-resistance. This review summarizes the field of DHFR inhibition with special focus on recent efforts to effectively interface computational and experimental efforts to discover novel classes of inhibitors that target allosteric and active-sites in drug-resistant variants of EcDHFR.
大肠杆菌二氢叶酸还原酶是一种重要的酶,对革兰氏阴性微生物的生存至关重要。针对这种酶设计的抑制剂已被证明可作为抗生素应用。然而,由于革兰氏阴性菌中双膜不能穿透导致小分子的生物利用度差,或者由于微生物通过突变 DHFR 靶标对抗生素产生耐药性,因此必须发现针对该酶的新抗生素来克服耐药性。本综述总结了 DHFR 抑制领域,特别关注最近努力有效结合计算和实验工作,以发现针对 EcDHFR 耐药变体的变构和活性部位的新型抑制剂。